Kjellson Nina S

DirectorTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Nov 8, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2024Sell(S)2K$17.32$41K449K
Nov 7, 2024Sell(S)20K$17.32$342K3.7M
Nov 6, 2024Sell(S)47K$17.18$805K3.8M
Nov 6, 2024Sell(S)6K$17.18$97K452K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-124184) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about TYRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-124184"
Ask your agent
Use Arkolith to summarize insider buying and selling at Tyra Biosciences, Inc.
over the last 90 days and cite the filings.